Skip to main content
Premium Trial:

Request an Annual Quote

PerkinElmer Closes Euroscreen and Evotec Acquisitions

NEW YORK (GenomeWeb News) — PerkinElmer has closed its acquisition of Euroscreen Products and Evotec Technologies, the company said Wednesday.
 
PerkinElmer paid $30.5 million for Evotec, a German company that makes and sells tools for high-throughput and high-content cell and biochemical screening.
 
The company did not disclose the purchase price for the Belgium-based Euroscreen, which provides GPCR membranes, cell lines, and an aequorin-based cellular assay to drug makers.
 
PerkinElmer said ongoing revenue for the combined companies in 2006 was around $25 million, and said the acquisitions should be “neutral to slightly accretive” for its 2007 earnings per share.
 
On Jan. 2 PerkinElmer said it bought the thermal-analysis product line from the British company Triton Technologies.
The Scan

Booster for At-Risk

The New York Times reports that the US Food and Drug Administration has authorized a third dose of the Pfizer-BioNTech SARS-CoV-2 vaccine for people 65 and older or at increased risk.

Preprints OK to Mention Again

Nature News reports the Australian Research Council has changed its new policy and now allows preprints to be cited in grant applications.

Hundreds of Millions More to Share

The US plans to purchase and donate 500 million additional SARS-CoV-2 vaccine doses, according to the Washington Post.

Nature Papers Examine Molecular Program Differences Influencing Neural Cells, Population History of Polynesia

In Nature this week: changes in molecular program during embryonic development leads to different neural cell types, and more.